A Novel Multimodal Digital Service (Moderated Online Social Therapy+) for Help-Seeking Young People Experiencing Mental Ill-Health: Pilot Evaluation Within a National Youth E-Mental Health Service.


Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
13 08 2020
Historique:
received: 21 11 2019
accepted: 13 06 2020
revised: 12 05 2020
entrez: 14 8 2020
pubmed: 14 8 2020
medline: 16 1 2021
Statut: epublish

Résumé

Mental ill-health is the leading cause of disability worldwide. Moreover, 75% of mental health conditions emerge between the ages of 12 and 25 years. Unfortunately, due to lack of resources and limited engagement with services, a majority of young people affected by mental ill-health do not access evidence-based support. To address this gap, our team has developed a multimodal, scalable digital mental health service (Enhanced Moderated Online Social Therapy [MOST+]) merging real-time, clinician-delivered web chat counseling; interactive user-directed online therapy; expert and peer moderation; and peer-to-peer social networking. The primary aim of this study is to ascertain the feasibility, acceptability, and safety of MOST+. The secondary aims are to assess pre-post changes in clinical, psychosocial, and well-being outcomes and to explore the correlations between system use, perceived helpfulness, and secondary outcome variables. Overall, 157 young people seeking help from a national youth e-mental health service were recruited over 5 weeks. MOST+ was active for 9 weeks. All participants had access to interactive online therapy and integrated web chat counseling. Additional access to peer-to-peer social networking was granted to 73 participants (46.5%) for whom it was deemed safe. The intervention was evaluated via an uncontrolled single-group study. Overall, 93 participants completed the follow-up assessment. Most participants had moderate (52/157, 33%) to severe (96/157, 61%) mental health conditions. All a priori feasibility, acceptability, and safety criteria were met. Participants provided mean scores of ≥3.5 (out of 5) on ease of use (mean 3.7, SD 1.1), relevancy (mean 3.9, SD 1.0), helpfulness (mean 3.5, SD 0.9), and overall experience (mean 3.9, SD 0.8). Moreover, 98% (91/93) of participants reported a positive experience using MOST+, 82% (70/93) reported that using MOST+ helped them feel better, 86% (76/93) felt more socially connected using it, and 92% (86/93) said they would recommend it to others. No serious adverse events or inappropriate use were detected, and 97% (90/93) of participants reported feeling safe. There were statistically significant improvements in 8 of the 11 secondary outcomes assessed: psychological distress (d=-0.39; P<.001), perceived stress (d=-0.44; P<.001), psychological well-being (d=0.51; P<.001), depression (d=-0.29; P<.001), loneliness (d=-0.23; P=.04), social support (d=0.30; P<.001), autonomy (d=0.36; P=.001), and self-competence (d=0.30; P<.001). There were significant correlations between system use, perceived helpfulness, and a number of secondary outcome variables. MOST+ is a feasible, acceptable, and safe online clinical service for young people with mental ill-health. The high level of perceived helpfulness, the significant improvements in secondary outcomes, and the correlations between indicators of system use and secondary outcome variables provide initial support for the therapeutic potential of MOST+. MOST+ is a promising and scalable platform to deliver standalone e-mental health services as well as enhance the growing international network of face-to-face youth mental health services.

Sections du résumé

BACKGROUND
Mental ill-health is the leading cause of disability worldwide. Moreover, 75% of mental health conditions emerge between the ages of 12 and 25 years. Unfortunately, due to lack of resources and limited engagement with services, a majority of young people affected by mental ill-health do not access evidence-based support. To address this gap, our team has developed a multimodal, scalable digital mental health service (Enhanced Moderated Online Social Therapy [MOST+]) merging real-time, clinician-delivered web chat counseling; interactive user-directed online therapy; expert and peer moderation; and peer-to-peer social networking.
OBJECTIVE
The primary aim of this study is to ascertain the feasibility, acceptability, and safety of MOST+. The secondary aims are to assess pre-post changes in clinical, psychosocial, and well-being outcomes and to explore the correlations between system use, perceived helpfulness, and secondary outcome variables.
METHODS
Overall, 157 young people seeking help from a national youth e-mental health service were recruited over 5 weeks. MOST+ was active for 9 weeks. All participants had access to interactive online therapy and integrated web chat counseling. Additional access to peer-to-peer social networking was granted to 73 participants (46.5%) for whom it was deemed safe. The intervention was evaluated via an uncontrolled single-group study.
RESULTS
Overall, 93 participants completed the follow-up assessment. Most participants had moderate (52/157, 33%) to severe (96/157, 61%) mental health conditions. All a priori feasibility, acceptability, and safety criteria were met. Participants provided mean scores of ≥3.5 (out of 5) on ease of use (mean 3.7, SD 1.1), relevancy (mean 3.9, SD 1.0), helpfulness (mean 3.5, SD 0.9), and overall experience (mean 3.9, SD 0.8). Moreover, 98% (91/93) of participants reported a positive experience using MOST+, 82% (70/93) reported that using MOST+ helped them feel better, 86% (76/93) felt more socially connected using it, and 92% (86/93) said they would recommend it to others. No serious adverse events or inappropriate use were detected, and 97% (90/93) of participants reported feeling safe. There were statistically significant improvements in 8 of the 11 secondary outcomes assessed: psychological distress (d=-0.39; P<.001), perceived stress (d=-0.44; P<.001), psychological well-being (d=0.51; P<.001), depression (d=-0.29; P<.001), loneliness (d=-0.23; P=.04), social support (d=0.30; P<.001), autonomy (d=0.36; P=.001), and self-competence (d=0.30; P<.001). There were significant correlations between system use, perceived helpfulness, and a number of secondary outcome variables.
CONCLUSIONS
MOST+ is a feasible, acceptable, and safe online clinical service for young people with mental ill-health. The high level of perceived helpfulness, the significant improvements in secondary outcomes, and the correlations between indicators of system use and secondary outcome variables provide initial support for the therapeutic potential of MOST+. MOST+ is a promising and scalable platform to deliver standalone e-mental health services as well as enhance the growing international network of face-to-face youth mental health services.

Identifiants

pubmed: 32788151
pii: v22i8e17155
doi: 10.2196/17155
pmc: PMC7453330
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e17155

Informations de copyright

©Mario Alvarez-Jimenez, Simon Rice, Simon D'Alfonso, Steven Leicester, Sarah Bendall, Ingrid Pryor, Penni Russon, Carla McEnery, Olga Santesteban-Echarri, Gustavo Da Costa, Tamsyn Gilbertson, Lee Valentine, Laia Solves, Aswin Ratheesh, Patrick D McGorry, John Gleeson. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 13.08.2020.

Références

Can J Psychiatry. 2013 Jul;58(7):376-85
pubmed: 23870719
Early Interv Psychiatry. 2019 Dec 30;:
pubmed: 31889431
J Med Internet Res. 2017 May 10;19(5):e153
pubmed: 28490417
J Med Internet Res. 2018 Dec 18;20(12):e12244
pubmed: 30563811
Internet Interv. 2020 May 08;20:100323
pubmed: 32435600
J Med Internet Res. 2014 Jun 04;16(6):e140
pubmed: 24901900
Front Psychiatry. 2019 Aug 14;10:581
pubmed: 31474889
NPJ Digit Med. 2019 Dec 2;2:118
pubmed: 31815193
Qual Health Res. 2016 Jul;26(8):1067-77
pubmed: 27179020
J Clin Psychol. 2013 Sep;69(9):994-1011
pubmed: 23630010
Clin Psychol Rev. 2018 Feb;59:52-60
pubmed: 29126747
J Med Internet Res. 2019 Sep 25;21(9):e14567
pubmed: 31573916
Schizophr Res. 2012 Aug;139(1-3):116-28
pubmed: 22658527
World Psychiatry. 2017 Oct;16(3):287-298
pubmed: 28941113
JMIR Ment Health. 2015 May 19;2(2):e19
pubmed: 26543923
BMJ. 2010 Mar 03;340:c863
pubmed: 20200064
Early Interv Psychiatry. 2018 Aug;12(4):613-625
pubmed: 27311581
Psychol Med. 2010 Dec;40(12):1943-57
pubmed: 20406528
Evid Based Ment Health. 2015 Nov;18(4):97-9
pubmed: 26459466
BMC Public Health. 2013 Feb 08;13:119
pubmed: 23390882
Aust N Z J Public Health. 2001 Dec;25(6):494-7
pubmed: 11824981
Med J Aust. 2007 Nov 19;187(10):556-60
pubmed: 18021042
Schizophr Res. 2013 Jan;143(1):143-9
pubmed: 23146146
JMIR Res Protoc. 2018 Feb 22;7(2):e48
pubmed: 29472177
Clin Psychol Rev. 2012 Jun;32(4):329-42
pubmed: 22466510
JMIR Ment Health. 2016 Aug 25;3(3):e40
pubmed: 27562729
Epidemiol Psichiatr Soc. 2008 Jan-Mar;17(1):14-9
pubmed: 18444452
J Affect Disord. 2017 Jan 01;207:163-166
pubmed: 27723539
Med Humanit. 2012 Jun;38(1):21-7
pubmed: 22282425
Asian Nurs Res (Korean Soc Nurs Sci). 2012 Dec;6(4):121-7
pubmed: 25031113
J Med Internet Res. 2019 Nov 19;21(11):e13873
pubmed: 31742562
Annu Rev Psychol. 2001;52:1-26
pubmed: 11148297
Front Psychol. 2017 Jun 02;8:796
pubmed: 28626431
Front Psychol. 2017 Apr 03;8:485
pubmed: 28421012
Early Interv Psychiatry. 2017 Aug;11(4):290-295
pubmed: 25808317
Soc Psychiatry Psychiatr Epidemiol. 2008 Feb;43(2):140-50
pubmed: 17994175
J R Soc Med. 2011 Dec;104(12):510-20
pubmed: 22179294
J Med Internet Res. 2015 Oct 13;17(10):e232
pubmed: 26462848
JMIR Mhealth Uhealth. 2020 May 22;8(5):e17798
pubmed: 32357125
J Affect Disord. 2013 Oct;151(1):298-305
pubmed: 23829999
Psychiatr Serv. 2002 May;53(5):565-73
pubmed: 11986504
JAMA Psychiatry. 2015 Apr;72(4):334-41
pubmed: 25671328
J Affect Disord. 2018 Oct 1;238:499-505
pubmed: 29936387
J Anxiety Disord. 2016 Aug;42:71-84
pubmed: 27376634
Epidemiol Psychiatr Sci. 2016 Apr;25(2):113-22
pubmed: 26744309
Psychol Methods. 2002 Mar;7(1):105-25
pubmed: 11928886
Depress Anxiety. 2016 Apr;33(4):323-31
pubmed: 26783723
Epidemiol Psychiatr Sci. 2013 Jun;22(2):147-50
pubmed: 23098565
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
J Pers Assess. 1996 Feb;66(1):20-40
pubmed: 8576833
BMJ Open. 2019 Feb 19;9(2):e024104
pubmed: 30782893
Br J Psychiatry. 2010 Mar;196(3):173-8
pubmed: 20194536
J Med Internet Res. 2011 Mar 10;13(1):e30
pubmed: 21393123
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Health Expect. 2017 Feb;20(1):98-111
pubmed: 26725547
BMC Psychiatry. 2010 Dec 30;10:113
pubmed: 21192795
J Med Internet Res. 2015 Aug 17;17(8):e198
pubmed: 26283290
Eat Disord. 2006 Jan-Feb;14(1):17-30
pubmed: 16757446
J Med Internet Res. 2014 Sep 16;16(9):e206
pubmed: 25226790
East Mediterr Health J. 2015 Sep 28;21(7):461-3
pubmed: 26442884
Int J Environ Res Public Health. 2020 Apr 03;17(7):
pubmed: 32260111
J Affect Disord. 2016 Mar 15;193:267-73
pubmed: 26774513
J Affect Disord. 2017 Aug 15;218:15-22
pubmed: 28456072
Am Psychol. 2000 Jan;55(1):68-78
pubmed: 11392867
JAMA Psychiatry. 2018 Feb 1;75(2):113-114
pubmed: 29238805
Soc Psychiatry Psychiatr Epidemiol. 2018 Mar;53(3):221-238
pubmed: 29327166
Clin Psychol Rev. 2016 Feb;43:1-16
pubmed: 26655959
J Abnorm Psychol. 1971 Aug;78(1):107-26
pubmed: 4938262
Trials. 2017 Jan 17;18(1):27
pubmed: 28095883
Schizophr Res. 2015 Dec;169(1-3):268-273
pubmed: 26527247
Br J Gen Pract. 2016 Oct;66(651):e686-92
pubmed: 27688518
Psychiatr Serv. 2018 Apr 1;69(4):377-388
pubmed: 29241435
JMIR Ment Health. 2017 Oct 30;4(4):e49
pubmed: 29084710
Health Qual Life Outcomes. 2007 Nov 27;5:63
pubmed: 18042300
Sleep Med. 2019 Sep;61:63-72
pubmed: 31262551
J Med Internet Res. 2012 Dec 31;15(1):e2
pubmed: 23302475
Lancet. 2007 Apr 14;369(9569):1302-1313
pubmed: 17434406
Schizophr Res. 2018 Dec;202:369-377
pubmed: 30031616
JAMA. 2016 May 3;315(17):1854-63
pubmed: 27139058
Ann Fam Med. 2010 Jul-Aug;8(4):348-53
pubmed: 20644190
JMIR Ment Health. 2018 Sep 25;5(3):e10278
pubmed: 30274963
J Med Internet Res. 2013 May 13;15(5):e82
pubmed: 23669884
J Adolesc Health. 2013 May;52(5):533-8
pubmed: 23499382
Br J Psychiatry. 2010 Aug;197(2):122-7
pubmed: 20679264
Psychiatr Serv. 2017 May 1;68(5):427-429
pubmed: 28412890

Auteurs

Mario Alvarez-Jimenez (M)

Orygen, Parkville, Australia.
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.

Simon Rice (S)

Orygen, Parkville, Australia.
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.

Simon D'Alfonso (S)

Orygen, Parkville, Australia.
The School of Computing and Information Systems, The University of Melbourne, Melbourne, Australia.

Steven Leicester (S)

headspace National Youth Mental Health Foundation, Melbourne, Australia.

Sarah Bendall (S)

Orygen, Parkville, Australia.
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.

Ingrid Pryor (I)

Orygen, Parkville, Australia.
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.

Penni Russon (P)

Orygen, Parkville, Australia.
School of Culture and Communications, The University of Melbourne, Melbourne, Australia.

Carla McEnery (C)

Orygen, Parkville, Australia.
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.
Centre for Mental Health, Swinburne University of Technology, Hawthorn, Australia.

Olga Santesteban-Echarri (O)

Hotchkiss Brain Institute, Psychiatry Department, University of Calgary, Calgary, AB, Canada.

Gustavo Da Costa (G)

The School of Computing and Information Systems, The University of Melbourne, Melbourne, Australia.

Lee Valentine (L)

Orygen, Parkville, Australia.
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.

Laia Solves (L)

Consorci Sanitari del Maresme, Department of Psychiatry, Hospital of Mataro, Mataro, Spain.

Aswin Ratheesh (A)

Orygen, Parkville, Australia.
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.

Patrick D McGorry (PD)

Orygen, Parkville, Australia.
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.

John Gleeson (J)

School of Behavioural and Health Sciences, Australian Catholic University, Melbourne, Australia.
Healthy Brain and Mind Research Centre, Australian Catholic University, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH